DJ ‐1 in human lenses: Potential role in preventing advanced glycation endproduct formation
Protein Science · 2025
DOI: 10.1002/pro.70375 ↗At a glance
Journal article in Protein Science, 2025. Written by Sandip K Nandi and 5 co-authors. Institution: Department of Chemistry, BITS Pilani, K. K. Birla Goa Campus, Goa, India. Major MEDLINE topics: Glycation End Products, Advanced, Lens, Crystalline. Cited 1 times so far (Crossref); 53 references. The full text is freely available in PubMed Central. Funded by: Department of Science and Technology, Ministry of Science and Technology, India, Department of Biotechnology, Ministry of Science and Technology, India, Research to Prevent Blindness, NY, to the Department of Ophthalmology, University of Colorado School of Medicine.
Abstract (original language)
The amino groups of lysine and arginine residues in proteins react with reducing sugars and carbonyl compounds to form advanced glycation endproducts (AGEs). Several AGEs have been detected in human lenses, and their levels have been shown to increase with age and cataract formation. AGEs can lead to structural changes, yellow pigmentation, and cross‐linking of lens proteins. Studies have shown a positive correlation between AGEs levels and lens age, stiffness, and cataracts. Recent research suggests that DJ‐1 can inhibit the accumulation of AGEs in cellular proteins by reversing the early glycation steps. Our study found that DJ‐1 is present in epithelial cells and the outer cortex of the human lens. DJ‐1 is catalytically active in human lenses, and its ability to metabolize methylglyoxal (MGO) into D‐lactate diminishes as the lens ages. The formation of MGH‐1 from MGO was promoted in lens proteins treated with the DJ‐1 inhibitor. Recombinant DJ‐1 prevents α‐dicarbonyl‐mediated cross‐linking and AGE accumulation in human αB‐crystallin. DJ‐1 prevents glyoxal‐mediated cell death and AGE accumulation in human lens epithelial cells. Taken together, our results suggest that DJ‐1 in the human lens hinders AGE accumulation. Enhancing its activity using pharmacological agents can potentially delay or prevent the onset of presbyopia and cataracts.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, BITS Pilani, K. K. Birla Goa Campus, Goa, India.
- Department of Ophthalmology, School of Medicine, University of Colorado, Aurora, Colorado, USA.
- School of Health Sciences and Technology, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India.
- Department of Ophthalmology, All India Institute of Medical Sciences, Rishikesh, India.
ORCID profiles: Sandip K Nandi
Funding
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Biotechnology, Ministry of Science and Technology, India
- Research to Prevent Blindness, NY, to the Department of Ophthalmology, University of Colorado School of Medicine
- Research to Prevent Blindness
Cite
APA
Nandi, S. K., Nahomi, R. B., Rathee, S., Gupta, N., Mittal, S. K., & Nagaraj, R. H. (2025). DJ ‐1 in human lenses: Potential role in preventing advanced glycation endproduct formation. Protein Science. https://doi.org/10.1002/pro.70375
Vancouver
Nandi SK, Nahomi RB, Rathee S, Gupta N, Mittal SK, Nagaraj RH. DJ ‐1 in human lenses: Potential role in preventing advanced glycation endproduct formation. Protein Science. 2025. doi:10.1002/pro.70375
BibTeX
@article{Nandi2025,
author = {Nandi, Sandip K and Nahomi, Rooban B and Rathee, Shivani and Gupta, Neeti and Mittal, Sanjeev Kumar and Nagaraj, Ram H},
title = {DJ ‐1 in human lenses: Potential role in preventing advanced glycation endproduct formation},
journal = {Protein Science},
year = {2025},
doi = {10.1002/pro.70375}
}
EUVIMED